FDA Approved: LEVOXYL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved Pfizer's supplemental application for LEVOXYL (levothyroxine sodium), resulting in labeling updates for its use in hypothyroidism and goiter.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Goiter
• Hypothyroidism

Drugs mentioned

• LEVOXYL (LEVOTHYROXINE SODIUM)

Snippet

SUPPL AP for LEVOXYL (LEVOTHYROXINE SODIUM)